Radiosensitizing effects of different size bovine serum albumin-templated gold nanoparticles on H22 hepatoma-bearing mice

Author:

Liu ShuLiang1,Piao JinMei1,Liu YunCai1,Tang JingLong1,Liu Peng2,Yang DaPeng3,Zhang Li1,Ge Nan1,Jin Zhezhen4,Jiang QiXiao5,Cui LianHua1

Affiliation:

1. Department of Toxicology, School of Public Health, Qingdao University, Qingdao 266021, Shandong, PR China

2. Radiology Department, Qingdao Haici Hospital, Qingdao 266033, Shandong, PR China

3. Fujian Province Key Laboratory for Preparation and Function Development of Active Substances from Marine Algae, School of Chemical Engineering & Materials Science, Quanzhou Normal University, Quanzhou 362000, Fujian, PR China

4. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA

5. Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao 266021, Shandong, PR China

Abstract

Aim: To evaluate intravenously injected bovine serum albumin-templated gold nanoparticles (BSA-GNPs) for radiosensitization effects on H22 hepatoma-bearing mice. Materials & methods: BSA-GNPs in different size were injected intravenously with a dose of 4 mg Au/kg. After 30 min injection, the tumor-bearing mice were irradiated with 5 Gy x-ray. Results: BSA-GNPs in 8, 50 and 187 nm were synthesized and have no obvious cytotoxicity to HeLa, HepG2 and HeCat cells when the concentration was up to 32 μM. And no obvious physiological injury of mice occurred when the intravenous injection dose was 4 mg Au/kg. In vivo study indicates 8 and 50 nm BSA-GNPs can inhibit tumor growth through inducing apoptosis in radiotherapy, with enhancement factors 1.93 and 2.02, respectively. Conclusion: BSA-GNPs in 8 and 50 nm are promising radiosensitizers in radiotherapy of subcutaneously transplanted hepatocarcinoma.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3